The study consisted of three parts: single ascending dose (D-2570: 3-48 mg once daily) study, multiple ascending dose (D-2570: 6-36 mg once …
A Site About 3D Stuff
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral TYK2 Inhibitor D …
Back To Top